Lonza expands in Houston; Dalton grows in Australia and DHL in India;

> Swiss drugmaker Lonza has completed construction of a clean room at its Houston site as it moves further into viral manufacturing. Story

> Fill and finish services helped CMO Dalton Pharma Services score a new Manufacturing Services Agreement with Clarity Pharmaceuticals of Sydney, Australia. Release

> BioCision in July will release new cooling technology to keep samples at a variety of temperatures for hours without ice. Item

> Shipper DHL has opened a 56,000-square-meter warehouse and distribution center in Mumbai, India, aimed at the country's life sciences and healthcare sector, including handling clinical trial services. Item

> Swedish CDMO Recipharm says it has invested €600,000 ($761,442) to expand its injectable drug filling capacity of its facility in Monts, France, capable of filling 7,200 cartridges an hour. Item

> The Federation of East African Pharmaceutical Manufacturers is pushing an initiative to increase production at least 50% in the next several years to make that part of Africa less dependent on drug imports. Story

And Finally... Generic drugmaker Amneal Pharmaceuticals is getting a $3 million boost from New York to help with its $50 million manufacturing project on Long Island where it will expand from 121,000 square feet to 443,000 square feet. Story

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.